ABOS
Acumen Pharmaceuticals, Inc.
$2.57
-0.10 (-3.75%)
At close · Jul 7
Market Cap
$196.10M
Shares
72,227,580
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-16 | 2026-06-12 | |
| 8-K | 2026-06-03 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| DEF 14A | 2026-04-23 | 2025-12-31 | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-03-26 | — | |
| 8-K | 2026-03-16 | 2026-03-13 | |
| 8-K | 2026-01-12 | — | |
| Investor Event Transcript | 2025-12-31 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-11-10 | 2025-11-06 | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-07-15 | — | |
| 8-K | 2025-06-05 | 2025-06-04 | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| DEF 14A | 2025-04-23 | 2025-06-04 | |
| 8-K | 2025-03-27 | — | |
| 10-K | 2025-03-27 | 2024-12-31 | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-06-05 | 2024-06-04 | |
| 8-K | 2024-05-14 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| DEF 14A | 2024-04-22 | 2024-06-04 | |
| 10-K | 2024-03-26 | 2023-12-31 | |
| 8-K | 2024-03-26 | — | |
| 8-K | 2024-03-19 | — | |
| 8-K | 2024-02-01 | — | |
| 8-K | 2024-01-12 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-12-04 | — | |
| 8-K | 2023-11-13 | — | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-11-13 | — | |
| 8-K | 2023-11-09 | 2023-11-05 | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-08-08 | — | |
| 8-K | 2023-07-20 | 2023-07-18 | |
| 8-K | 2023-07-17 | 2023-07-16 | |
| 8-K | 2023-07-17 | — | |
| 8-K | 2023-06-08 | 2023-06-06 | |
| 10-Q | 2023-05-09 | 2023-03-31 | |
| 8-K | 2023-05-09 | — |
Showing 1–50 of 79 filings